|
Viral Immunology
HIV-1 Extrachromosomal 2-LTR Circular DNA Is Long-Lived in Human Macrophages
To cite this article:
Laura Gillim-Ross, Andrea Cara, Mary E. Klotman.
Viral Immunology.
Spring 2005,
18(1): 190-196.
doi:10.1089/vim.2005.18.190.
Laura Gillim-Ross Mount Sinai School of Medicine, Division of Infectious Diseases, New York, New York. Andrea Cara Laboratory of Virology, Istituto Superiore di Sanità, Roma, Italy. Dr. Mary E. Klotman Mount Sinai School of Medicine, Division of Infectious Diseases, New York, New York. HIV-1 extrachromosomal 2-LTR circles (cc2LTR) are rapidly lost in dividing cell populations and, therefore, might be interpreted as representing new infection and ongoing viral replication. However, recent work demonstrated that cc2LTR persist in infected, growth-arrested T cell lines beyond their predicted half-life as previously determined in dividing cell populations. In this study, the evaluation of the stability of cc2LTR was extended to include primary human macrophages, a natural, non-dividing target of HIV-1. By quantitative real-time PCR, cc2LTR were found to persist out to 21 days post-infection in macrophages infected with both integrase competent and integrase- defective, recombinant HIV-1, whereas in activated CD4+ T lymphocytes, they rapidly decreased over time. This persistence was associated with persistent, low level expression of the indicator gene, luciferase. These data suggest that the presence of HIV-1 cc2LTR in the PBMC of HIV-1–infected patients on suppressive HAART could be due either to ongoing generation of newly infected dividing cells, or persistence of circles in non-dividing cell populations where they appear to be stable. Furthermore, exrachromosomal circular DNA in this cell population could be a source of persisent viral protein expression.  This paper was cited by:Integration-deficient Lentiviral Vectors: A Slow Coming of Age Klaus Wanisch, Rafael J Yáñez-Muñoz Molecular Therapy. Jul 2009 CrossRef A Large U3 Deletion Causes Increased In Vivo Expression From a Nonintegrating Lentiviral Vector Matthew Bayer, Boris Kantor, Adam Cockrell, Hong Ma, Brian Zeithaml, Xiangping Li, Thomas McCown, Tal Kafri Molecular Therapy. Jan 2009, Vol. 16, No. 12: 1968-1976 CrossRef Successful Immunization with a Single Injection of Non-integrating Lentiviral Vector Donatella RM Negri, Zuleika Michelini, Silvia Baroncelli, Massimo Spada, Silvia Vendetti, Viviana Buffa, Roberta Bona, Pasqualina Leone, Mary E Klotman, Andrea Cara Molecular Therapy. Oct 2007, Vol. 15, No. 9: 1716-1723 CrossRef Role of macrophages in HIV infection and persistence Stephanie Venzke, Oliver T Keppler Expert Review of Clinical Immunology. Aug 2006, Vol. 2, No. 4: 613-626 CrossRef
|
|